TF and anemia: Additionally, the chronic inflammatory state in CKD patients can affect the glycosylation modification of transferrin (TF), leading to changes in the proportion of TF variants, which in turn impairs iron transport efficiency and exacerbates anemia (Formanowicz and Formanowicz, 2012).